Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed / Refractory Osteosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT04539366
What this trial is testing

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial

Who this might be right for
Recurrent Childhood NeuroblastomaRecurrent Childhood OsteosarcomaRecurrent Neuroblastoma+5 more
National Cancer Institute (NCI) 73
Early research (Phase 1)UnknownNCT06412458
What this trial is testing

IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma

Who this might be right for
Refractory OsteosarcomaRecurrent Osteosarcoma
Beijing Immunochina Medical Science & Technology Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT05277480
What this trial is testing

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

Who this might be right for
Effect of DrugDrugToxicity
Peking University People's Hospital 81
Early research (Phase 1)Study completedNCT04661852
What this trial is testing

Cabozantinib With Topotecan-Cyclophosphamide

Who this might be right for
Relapsed Ewing SarcomaRefractory Ewing SarcomaRelapsed Osteosarcoma+1 more
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Looking for participantsNCT05830123
What this trial is testing

ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

Who this might be right for
OsteosarcomaSarcoma
Hansoh BioMedical R&D Company 170
Testing effectiveness (Phase 2)Study completedNCT03275818
What this trial is testing

Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma

Who this might be right for
Tumor, Desmoplastic Small Round Cell, AdultTumor, Desmoplastic Small Round Cell, ChildhoodSarcoma, Ewing+2 more
Grupo Espanol de Investigacion en Sarcomas 69
Testing effectiveness (Phase 2)Looking for participantsNCT07725380
What this trial is testing

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Who this might be right for
SarcomaOsteosarcoma
H. Lee Moffitt Cancer Center and Research Institute 74
Not applicableStudy completedNCT02162732
What this trial is testing

Molecular-Guided Therapy for Childhood Cancer

Who this might be right for
NeuroblastomaMedulloblastomaGlioma+16 more
Giselle Sholler 186
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567
What this trial is testing

Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Who this might be right for
MelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more
GlaxoSmithKline 83
Testing effectiveness (Phase 2)Temporarily pausedNCT04890093
What this trial is testing

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Sarcoma, EwingRhabdomyosarcoma
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT00563680
What this trial is testing

QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors

Who this might be right for
Askin's TumorsDesmoplastic Small Round Cell TumorsEstraosseous Ewing's Tumor+4 more
NantCell, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT02432274
What this trial is testing

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Who this might be right for
TumorsSolid Malignant TumorsOsteosarcoma+1 more
Eisai Limited 117
Testing effectiveness (Phase 2)UnknownNCT00180947
What this trial is testing

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Who this might be right for
RhabdomyosarcomasNeoplasms, Connective and Soft TissueEwing Tumor+3 more
Gustave Roussy, Cancer Campus, Grand Paris 210
Testing effectiveness (Phase 2)Looking for participantsNCT05734066
What this trial is testing

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Who this might be right for
Refractory Ewing SarcomaRelapsed Ewing SarcomaEwing Sarcoma
Jazz Pharmaceuticals 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)UnknownNCT06125171
What this trial is testing

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Who this might be right for
Osteosarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 46
Testing effectiveness (Phase 2)Looking for participantsNCT06709495
What this trial is testing

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Who this might be right for
SarcomaSarcoma, EwingDesmoplastic Small Round Cell Tumor+3 more
David S Shulman, MD 63
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Looking for participantsNCT07144254
What this trial is testing

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

Who this might be right for
Osteosarcoma RecurrentOsteosarcoma in ChildrenRelapsed Osteosarcoma+1 more
Emory University 24
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Next Page